AUD 0.25
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 992.24 Thousand AUD | 49.21% |
2023 | 665.01 Thousand AUD | 43969.58% |
2022 | 1509.00 AUD | -99.02% |
2021 | 153.37 Thousand AUD | 855.9% |
2020 | 16.04 Thousand AUD | -97.45% |
2019 | 628.75 Thousand AUD | 2657.71% |
2018 | 22.8 Thousand AUD | -96.75% |
2017 | 700.68 Thousand AUD | 44359.9% |
2016 | 1576.00 AUD | 383.44% |
2015 | 326.00 AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q4 | 992.24 Thousand AUD | 0.0% |
2024 Q1 | 1.11 Million AUD | 67.24% |
2024 Q2 | 1.11 Million AUD | 0.0% |
2024 Q3 | 992.24 Thousand AUD | -10.78% |
2024 FY | 992.24 Thousand AUD | 49.21% |
2023 Q3 | 665.01 Thousand AUD | 21575.68% |
2023 FY | 665.01 Thousand AUD | 43969.58% |
2023 Q4 | 665.01 Thousand AUD | 0.0% |
2023 Q2 | 3068.00 AUD | 0.0% |
2023 Q1 | 3068.00 AUD | 103.31% |
2022 Q1 | 571.3 Thousand AUD | 272.49% |
2022 FY | 1509.00 AUD | -99.02% |
2022 Q4 | 1509.00 AUD | 0.0% |
2022 Q3 | 1509.00 AUD | -99.74% |
2022 Q2 | 571.3 Thousand AUD | 0.0% |
2021 FY | 153.37 Thousand AUD | 855.9% |
2021 Q2 | 164.68 Thousand AUD | 0.0% |
2021 Q1 | 164.68 Thousand AUD | 926.41% |
2021 Q3 | 153.37 Thousand AUD | -6.87% |
2021 Q4 | 153.37 Thousand AUD | 0.0% |
2020 Q4 | 16.04 Thousand AUD | 0.0% |
2020 Q1 | 5292.00 AUD | -99.16% |
2020 FY | 16.04 Thousand AUD | -97.45% |
2020 Q2 | 5292.00 AUD | 0.0% |
2020 Q3 | 16.04 Thousand AUD | 203.19% |
2019 FY | 628.75 Thousand AUD | 2657.71% |
2019 Q4 | 628.75 Thousand AUD | 0.0% |
2019 Q3 | 628.75 Thousand AUD | 0.0% |
2019 Q1 | - AUD | 0.0% |
2018 FY | 22.8 Thousand AUD | -96.75% |
2017 FY | 700.68 Thousand AUD | 44359.9% |
2016 FY | 1576.00 AUD | 383.44% |
2015 FY | 326.00 AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Adherium Limited | 1.58 Million AUD | 37.291% |
Aroa Biosurgery Limited | 7.43 Million AUD | 86.646% |
Atomo Diagnostics Limited | 1.83 Million AUD | 46.037% |
Anteris Technologies Ltd | 646.71 Thousand AUD | -53.43% |
Control Bionics Limited | 404.15 Thousand AUD | -145.515% |
CardieX Limited | 2.55 Million AUD | 61.142% |
Compumedics Limited | 13.21 Million AUD | 92.489% |
Cochlear Limited | 391.6 Million AUD | 99.747% |
CleanSpace Holdings Limited | 2.86 Million AUD | 65.372% |
Cyclopharm Limited | 10.12 Million AUD | 90.197% |
EMVision Medical Devices Ltd | - AUD | -Infinity% |
Nova Eye Medical Limited | 4.28 Million AUD | 76.833% |
HeraMED Limited | 361.61 Thousand AUD | -174.396% |
Imricor Medical Systems, Inc. | 2.46 Million AUD | 59.731% |
ImpediMed Limited | 759 Thousand AUD | -30.731% |
InhaleRx Limited | - AUD | -Infinity% |
LBT Innovations Limited | 1.61 Million AUD | 38.674% |
Micro-X Limited | 5.37 Million AUD | 81.553% |
Neurotech International Limited | - AUD | -Infinity% |
OncoSil Medical Limited | 391.67 Thousand AUD | -153.337% |
PolyNovo Limited | 8.97 Million AUD | 88.941% |
Respiri Limited | 2.75 Million AUD | 63.939% |
SomnoMed Limited | 6.28 Million AUD | 84.213% |
Universal Biosensors, Inc. | 4.37 Million AUD | 77.335% |
Uscom Limited | 623.62 Thousand AUD | -59.11% |
Visioneering Technologies, Inc. | 3.16 Million AUD | 68.669% |